HOME >> MEDICINE >> NEWS
More doubts over value of defibrillators

Use of defibrillators by police and fire fighters to emergency calls shows only a modest benefit, finds a study in this week's BMJ. A second study shows that public place defibrillators are not good value for money.

In the first study, defibrillators were provided to one fire brigade region and two police districts in and around Amsterdam. Half of the fire brigade region and police districts served as the control area. Every four months the experimental and control areas changed over.

Use of defibrillators did not significantly increase survival to hospital discharge, although it did improve return of spontaneous circulation and admission to hospital. The authors suggest that improved dispatch procedures should increase the success of the programme.

In the second study, researchers calculated the cost efficiency of locating defibrillators in all major airports, railway stations, and bus stations across Scotland.

They concluded that public place defibrillators exceed the commonly used cut-off levels for funding and represent poorer value for money than some alternative strategies.


'"/>

Contact: Emma Dickinson
edickinson@bmj.com
44-207-383-6529
BMJ-British Medical Journal
4-Dec-2003


Page: 1

Related medicine news :

1. Men with prostate cancer want screening despite doubts over effectiveness of treatment
2. Study investigates value of center of excellence designation
3. Health state values for patients with CAD vary according to the measure used to generate them
4. Concerns over the value of animal experiments
5. UK trial results on value of cannabis for multiple sclerosis patients
6. Zimbabwean women value diaphragm as clandestine method to possibly prevent HIV
7. Survey of medical students affirms value of student diversity
8. Nutritional value of enriched egg yolks as a weaning food for infants
9. PFI hospitals are not value for money
10. Misclassification of death may influence perceived value of cancer screening
11. Dartmouth research examines the value of cancer screening

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: More doubts over value defibrillators

(Date:8/4/2015)... ... 04, 2015 , ... Nathan’s Famous was recently featured on NewsWatch ... large businesses making an impact in their industry. Andrew Tropeano, the host of NewsWatch ... hot dog maker now offers a 50% Reduced Fat All-Beef Frank variety and ...
(Date:8/4/2015)... , ... August 04, 2015 , ... ... Winscribe Text results have been impressive so far". , Mr Cauchois attributes ... from Winscribe's French sales partner Dicma and the healthcare technology offered by Winscribe's ...
(Date:8/3/2015)... ... August 04, 2015 , ... While the pace of the economic recovery since the ... clearly been on a growth trajectory for the last six years. Unemployment has dropped from ... trending at a 3.5 percent growth rate in 2014, the U.S. stock market is at ...
(Date:8/3/2015)... ... 03, 2015 , ... Zeiter’s Septic now performs septic installations ... and operated business, Zeiter’s Septic has been serving the community for over 20 ... because of their continued training and perseverance to provide their customers with new ...
(Date:8/3/2015)... (PRWEB) , ... August 03, 2015 , ... Code ... the T500 cable , a Bluetooth Code Reader accessory that enables a wireless ... products. The T500 helps enable a variety of barcode reading applications with iPads, ...
Breaking Medicine News(10 mins):Health News:Celebrate Summer with Nathan’s Famous Original Selfie Sweepstakes 2Health News:Celebrate Summer with Nathan’s Famous Original Selfie Sweepstakes 3Health News:The Oscar Lambret Center (France) Completes First Stage Of Winscribe Text Rollout 2Health News:The Oscar Lambret Center (France) Completes First Stage Of Winscribe Text Rollout 3Health News:The Oscar Lambret Center (France) Completes First Stage Of Winscribe Text Rollout 4Health News:Newport Board group, an Advisory Firm Serving the Middle Market, Cautions Businesses on How to Survive the Coming Recession 2Health News:Newport Board group, an Advisory Firm Serving the Middle Market, Cautions Businesses on How to Survive the Coming Recession 3Health News:Newport Board group, an Advisory Firm Serving the Middle Market, Cautions Businesses on How to Survive the Coming Recession 4Health News:Zeiter’s Septics Performs Affordable Septic Installations Throughout Livingston & Putnam Counties Effective Immediately 2Health News:Zeiter’s Septics Performs Affordable Septic Installations Throughout Livingston & Putnam Counties Effective Immediately 3Health News:Code Launches the T500, an Innovative Code Reader Accessory 2Health News:Code Launches the T500, an Innovative Code Reader Accessory 3
(Date:8/3/2015)... -- Depomed, Inc. (NASDAQ: DEPO ) ("Depomed" or the ... HZNP ) ("Horizon") announcement that it intends to request ... record date to determine the shareholders eligible to request ... will review the request when it is received. Provided ... information required under Depomed,s bylaws, the Depomed Board will, ...
(Date:8/3/2015)... 3, 2015 Cooperative ... military surgical research and top-tier universities for ... to severe wound treatments for critical-care patients ... medicine and tissue-engineered skin substitute advancements.  Biotech ... in focus are Amarantus Bioscience Holdings, Inc. ...
(Date:8/3/2015)... SINGAPORE , Aug. 3, 2015 ... Bloomberg: BIG SP; Reuters: BIOS.SI; SGX: B20), a ... today announced financial results for its first fiscal ... Quarter Highlights and Recent Developments: ... progress in improving its cost structure, driven by ...
Breaking Medicine Technology:Depomed Comments on Horizon Pharma Announcement 2Depomed Comments on Horizon Pharma Announcement 3Depomed Comments on Horizon Pharma Announcement 4Depomed Comments on Horizon Pharma Announcement 5Depomed Comments on Horizon Pharma Announcement 6Biotech Advancements Coupled with Collaborative Partnerships Focus on Developing Orphan Drug Products & Treatments for Critical-Care Patients With Severe Wound Conditions 2Biotech Advancements Coupled with Collaborative Partnerships Focus on Developing Orphan Drug Products & Treatments for Critical-Care Patients With Severe Wound Conditions 3Biotech Advancements Coupled with Collaborative Partnerships Focus on Developing Orphan Drug Products & Treatments for Critical-Care Patients With Severe Wound Conditions 4Biotech Advancements Coupled with Collaborative Partnerships Focus on Developing Orphan Drug Products & Treatments for Critical-Care Patients With Severe Wound Conditions 5Biotech Advancements Coupled with Collaborative Partnerships Focus on Developing Orphan Drug Products & Treatments for Critical-Care Patients With Severe Wound Conditions 6Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016 2Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016 3Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016 4Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016 5Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016 6
Cached News: